Cag repeat size and clinical presentation in huntington’s disease

Neurology

Volumn 44, Issue 6, 1994, Pages 1137-1143

  Ashizawa, Tetsuo ^a   Wong, L J C ^a   Richards, C S ^a   Caskey, C T ^a   Jankovic, J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE;

ADULT; AGED; ARTICLE; CHROMOSOME 4P; CLINICAL ARTICLE; DISEASE COURSE; FAMILIAL DISEASE; FEMALE; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PATERNITY; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; CASE REPORT; DNA; FEMALE; HUMAN; HUNTINGTON DISEASE; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0028234787     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.6.1137     Document Type: Article

References (43)

1. Re Martin JB, Gusella JF. Huntington’s disease: pathogenesis and management. N Engl J Med 1986;315:1267-1276.
2. Penney JB, Young AB. Huntington’s disease. In: Jankovic J, Tolosa E, eds. Parkinson’s disease and movement disorders, 2nd ed. Baltimore: Williams and Wilkins, 1993:205-216.
3. Thompson PD, Perardelli A, Rothwell JC, et al. The coexistence of bradykinesia and chorea in Huntington’s disease and its implications for theories of basal ganglia control of movement. Brain 1993;111:223-244.
4. Farrer LA, Cupples LA, Kiely DK, Conneally PM, Myers RH. Inverse relationship between age at onset of Huntington disease and paternal age suggests involvement of genetic imprinting. Am J Hum Genet 1992;50:528-535.
5. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 1983;306:234-238.
6. Roberts L. The Huntington’s gene quest goes on. Science1992;258:740-741.
7. The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993;72:971-983.
8. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fis- chbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79.
9. Amato AA, Prior TW, Barohn RJ, Snyder P, Papp A, Mendell JR. Kennedy’s disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 1993;43:791-794.
10. Fu Y-H, Kuhl DPA, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-1058.
11. Knight SJL, Flannery AV, Hirst MC, et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 1993;74:127-134.
12. Fu Y-H, Pizzuti A, Fenwick RG, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
13. Orr HT, Chung M-Y, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet 1993;4:221-226.
14. Ashizawa T, Dubel JR, Dunne PW, et al. Anticipation in myotonic dystrophy. II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology 1992;42:1877-1883.
15. Redman JB, Fenwick RG, Fu Y-H, Pizzuti A, Caskey CT. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA 1993;269:1960-1965.
16. Lavedan C, Hofmann-Radvanyi H, Shelbourne P, et al. Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet 1993;52:875-883.
17. Harley H, Rundle SA, MacMillan JC, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52:1164-1174.
18. Ashizawa T, Dunne PW, Ward PA, Seltzer WK, Richards CS. Effects of the sex of myotonic dystrophy patients on the unstable triplet repeat in their affected offspring. Neurology 1994;44:120-122.
19. rau F, Heite D, Bianceet al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 1991;325:1673-1681.
20. Myers RH, Vonsattel JP, Stevens TJ, et al. Clinical and neu- ropathologic assessment of severity in Huntington’s disease. Neurology 1988;38:341-347.
21. Verkerk AJMH, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-914.
22. Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nature Genet 1993;4:393-397.
23. Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nature Genet 1993;4:387-392.
24. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nature Genet 1993;4:398-403.
25. Bateman D, Boughey AM, Scaravilli F, Marsden CD, Harding AE. A follow-up study of isolated cases of suspected Huntington’s disease. Ann Neurol 1992;31:293-298.
26. Vance JM, Pericak-Vance MA, Bowman MH, et al. Chorea- acanthocytosis: a report of three new families and implications for genetic counselling. Am J Med Genet 1987;28:403-410.
27. Jankovic J, Killian JM, Spitz MC. Neuroacanthocytosis syndrome and choreoacanthocytosis (Levine-Critchley syndrome) [reply to letter]. Neurology 1985;35:1679.
28. Caskey CT, Pizzuti A, Fu YH, Fenwick RG Jr, Nelson DL. Triplet repeat mutations in human disease. Science 1992;256:784-789.
29. Hunter A, Tsilfidis C, Mettler G, et al. The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 1992;29:774-779.
30. Ridley RM, Frith CD, Farrer LA, Conneally PM. Patterns of inheritance of the symptoms of Huntington’s disease suggestive of an effect of genomic imprinting. J Med Genet 1991;28:224-231.
31. van Dijik JG, van der Velde EA, Roos RAC, Bruyn GW. Juvenile Huntington disease. Hum Genet 1986;73:235-239.
32. Reik W. Genomic imprinting: a possible mechanism for the parental origin effect in Huntington’s chorea. J Med Genet 1988;25:805-808.
33. Reik W, Maher ER, Morrison PJ, Harding AE, Simpson SA. Age at onset in Huntington’s disease and methylation at D4S95. J Med Genet 1993;30:185-188.
34. Roos RA, Hermans J, Vegter van der Vlis M, van Ommen GJ, Bruyn GW. Duration of illness in Huntington’s disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993;56:98-100.
35. Penney JB Jr, Young AB, Shoulson I, et al. Huntington’s disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 1990;5:93-99.
36. Ashizawa T, Dubel JR, Harati Y. Somatic instability of CTG repeat in myotonic dystrophy. Neurology 1993;43:2674-2678.
37. Reyniers E, Vits L, De Boulle K, et al. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nature Genet 1993;4:143-146.
38. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA. Correlation between the onset age of Huntington’s disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet 1993;2:1547-1549.
39. Norremolle A, Riess O, Epplen JT, Fenger K, Hasholt L, Sorensen SA. Trinucleotide repeat elongation in the Huntington gene in Huntington disease patients from 71 Danish families. Hum Mol Genet 1993;2:1475-1476.
40. Ziihlke C, Riess O, Schroder K, et al. Expansion of the (CAG)n repeat causing Huntington’s disease in 352 patients of German origin. Hum Mol Genet 1993;2:1467-1469.
41. Telenius H, Kremer HPH, Theilmann J, et al. Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Hum Mol Genet 1993;2:1535-1540.
42. Goldberg YP, Kremer B, Andrew SE, et al. Molecular analysis of new mutations for Huntington’s disease: intermediate alleles and sex of origin effects. Nature Genet 1993;5:174-179.
43. Rubinsztein DC, Barton DE, Davison BCC, Ferguson-Smith MA. Analysis of the Huntington gene reveals a trinu- cleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington’s disease and CAG repeat number. Hum Mol Genet 1993;2:1713-1715.